220 related articles for article (PubMed ID: 22001876)
1. Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.
Jenikova G; Hruz P; Andersson MK; Tejman-Yarden N; Ferreira PC; Andersen YS; Davids BJ; Gillin FD; Svärd SG; Curtiss R; Eckmann L
Vaccine; 2011 Nov; 29(51):9529-37. PubMed ID: 22001876
[TBL] [Abstract][Full Text] [Related]
2. Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia.
Davids BJ; Liu CM; Hanson EM; Le CHY; Ang J; Hanevik K; Fischer M; Radunovic M; Langeland N; Ferella M; Svärd SG; Ghassemian M; Miyamoto Y; Eckmann L
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962402
[No Abstract] [Full Text] [Related]
3. Vaccination with Bivalent DNA Vaccine of α1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.
Feng XM; Zheng WY; Zhang HM; Shi WY; Li Y; Cui BJ; Wang HY
PLoS One; 2016; 11(6):e0157872. PubMed ID: 27332547
[TBL] [Abstract][Full Text] [Related]
4. Systemic and local antibody response in mice induced by a recombinant peptide fragment from Giardia lamblia variant surface protein (VSP) H7 produced by a Salmonella typhimurium vaccine strain.
Stäger S; Gottstein B; Müller N
Int J Parasitol; 1997 Aug; 27(8):965-71. PubMed ID: 9292314
[TBL] [Abstract][Full Text] [Related]
5. Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle.
Abdul-Wahid A; Faubert G
Vaccine; 2007 Dec; 25(50):8372-83. PubMed ID: 17996337
[TBL] [Abstract][Full Text] [Related]
6. Immunodominant proteins α-1 giardin and β-giardin are expressed in both assemblages A and B of Giardia lamblia.
Feliziani C; Merino MC; Rivero MR; Hellman U; Pistoresi-Palencia MC; Rópolo AS
BMC Microbiol; 2011 Oct; 11():233. PubMed ID: 22011206
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
8. Mucosal vaccination in a murine gnotobiotic model of
Ihara S; Nguyen BV; Miyamoto Y; Eckmann L
Infect Immun; 2024 Jun; 92(6):e0006524. PubMed ID: 38722167
[No Abstract] [Full Text] [Related]
9. Identification of α-11 giardin as a flagellar and surface component of Giardia lamblia.
Kim J; Lee HY; Lee MA; Yong TS; Lee KH; Park SJ
Exp Parasitol; 2013 Oct; 135(2):227-33. PubMed ID: 23891940
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the ventral disc protein delta-giardin prevent in vitro binding of Giardia lamblia trophozoites.
Jenkins MC; O'Brien CN; Murphy C; Schwarz R; Miska K; Rosenthal B; Trout JM
J Parasitol; 2009 Aug; 95(4):895-9. PubMed ID: 19702359
[TBL] [Abstract][Full Text] [Related]
11. Giardia vaccination.
Olson ME; Ceri H; Morck DW
Parasitol Today; 2000 May; 16(5):213-7. PubMed ID: 10782082
[TBL] [Abstract][Full Text] [Related]
12. Conserved metabolic enzymes as vaccine antigens for giardiasis.
Ihara S; Miyamoto Y; Le CHY; Tran VN; Hanson EM; Fischer M; Hanevik K; Eckmann L
PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010323. PubMed ID: 35468132
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii.
Lee P; Abdul-Wahid A; Faubert GM
Microbes Infect; 2009 Jan; 11(1):20-8. PubMed ID: 18992359
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal cohort study of serum antibody responses towards Giardia lamblia variant-specific surface proteins in a non-endemic area.
Hjøllo T; Bratland E; Steinsland H; Radunovic M; Langeland N; Hanevik K
Exp Parasitol; 2018 Aug; 191():66-72. PubMed ID: 29908864
[TBL] [Abstract][Full Text] [Related]
15. Characterization of BIP protein of G. lamblia as a potential immunogen in a mouse infection model.
Lopez-Romero G; Garzon T; Rascon R; Valdez A; Quintero J; Arvizu-Flores AA; Garibay-Escobar A; Rascon L; Astiazarán-García H; Velazquez C
Immunobiology; 2017 Aug; 222(8-9):884-891. PubMed ID: 28552268
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an immunodominant Giardia lamblia protein antigen related to alpha giardin.
Wenman WM; Meuser RU; Nyugen Q; Kilani RT; el-Shewy K; Sherburne R
Parasitol Res; 1993; 79(7):587-92. PubMed ID: 8278341
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization of BALB/c mice with Giardia duodenalis recombinant cyst wall protein inhibits shedding of cysts.
Larocque R; Nakagaki K; Lee P; Abdul-Wahid A; Faubert GM
Infect Immun; 2003 Oct; 71(10):5662-9. PubMed ID: 14500486
[TBL] [Abstract][Full Text] [Related]
18. Resistance to reinfection in mice as a vaccine model for giardiasis.
Li E; Liu M; Singer SM
Hum Vaccin Immunother; 2014; 10(6):1536-43. PubMed ID: 24805818
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in potential Giardia vaccine candidates cyst wall protein 2 and α1-giardin.
Radunovic M; Klotz C; Saghaug CS; Brattbakk HR; Aebischer T; Langeland N; Hanevik K
Parasitol Res; 2017 Aug; 116(8):2151-2158. PubMed ID: 28578460
[TBL] [Abstract][Full Text] [Related]
20. Secretory antibodies against Giardia intestinalis in lactating Nicaraguan women.
Téllez A; Palm D; Weiland M; Alemán J; Winiecka-Krusnell J; Linder E; Svärd S
Parasite Immunol; 2005 May; 27(5):163-9. PubMed ID: 15987339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
